Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OraCare is a private U.S. dental healthcare company that develops and markets professional oral rinse and related oral care products for use through dental practices. Its flagship two-bottle rinse system generates activated chlorine dioxide and includes xylitol, positioning the product as an alternative to chlorhexidine for reducing oral pathogens and biofilm without common chlorhexidine-associated side effects. The company sells primarily through dental professionals rather than broad retail channels and has expanded its product line to include pre-rinse, orthodontic-focused rinse, toothpaste, and other adjunctive oral care products. OraCare was created by dentists and is led by CEO Dr. Robert Martino, with roots in Bridgeport, West Virginia. The business appears to be a commercial-stage oral health products company rather than a therapeutic biotech or drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OraCare.